Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ALKS |
---|---|---|
09:32 ET | 10615 | 24.12 |
09:34 ET | 600 | 24.19 |
09:36 ET | 3894 | 24.105 |
09:38 ET | 2200 | 23.97 |
09:39 ET | 1398 | 24.19 |
09:41 ET | 2480 | 24.19 |
09:43 ET | 2927 | 24.22 |
09:45 ET | 2550 | 24.23 |
09:48 ET | 3470 | 24.2 |
09:50 ET | 1100 | 24.225 |
09:52 ET | 9547 | 24.38 |
09:54 ET | 3300 | 24.415 |
09:56 ET | 3989 | 24.44 |
09:57 ET | 1161 | 24.45 |
09:59 ET | 3086 | 24.44 |
10:01 ET | 5765 | 24.37 |
10:03 ET | 3997 | 24.31 |
10:06 ET | 2358 | 24.3 |
10:08 ET | 1626 | 24.31 |
10:10 ET | 3171 | 24.33 |
10:12 ET | 3400 | 24.35 |
10:14 ET | 4518 | 24.34 |
10:15 ET | 2503 | 24.41 |
10:17 ET | 3039 | 24.42 |
10:19 ET | 3096 | 24.45 |
10:21 ET | 1700 | 24.48 |
10:24 ET | 4647 | 24.445 |
10:26 ET | 4619 | 24.47 |
10:28 ET | 3300 | 24.39 |
10:30 ET | 5826 | 24.37 |
10:32 ET | 1564 | 24.38 |
10:33 ET | 4155 | 24.34 |
10:35 ET | 2250 | 24.35 |
10:37 ET | 2400 | 24.36 |
10:39 ET | 2800 | 24.375 |
10:42 ET | 9751 | 24.41 |
10:44 ET | 5077 | 24.41 |
10:46 ET | 2114 | 24.445 |
10:48 ET | 6148 | 24.385 |
10:50 ET | 11997 | 24.26 |
10:51 ET | 9403 | 24.315 |
10:53 ET | 3702 | 24.265 |
10:55 ET | 4464 | 24.24 |
10:57 ET | 5437 | 24.27 |
11:00 ET | 5200 | 24.23 |
11:02 ET | 4182 | 24.24 |
11:04 ET | 1235 | 24.27 |
11:06 ET | 3234 | 24.26 |
11:08 ET | 2286 | 24.28 |
11:09 ET | 3585 | 24.27 |
11:11 ET | 3785 | 24.26 |
11:13 ET | 2561 | 24.26 |
11:15 ET | 3029 | 24.25 |
11:18 ET | 4438 | 24.17 |
11:20 ET | 2702 | 24.19 |
11:22 ET | 2415 | 24.11 |
11:24 ET | 1700 | 24.11 |
11:26 ET | 2167 | 24.08 |
11:27 ET | 1337 | 24.0179 |
11:29 ET | 5048 | 24.03 |
11:31 ET | 2255 | 23.98 |
11:33 ET | 1907 | 24.01 |
11:36 ET | 900 | 24.04 |
11:38 ET | 1393 | 24.04 |
11:40 ET | 1438 | 24.025 |
11:42 ET | 3267 | 24 |
11:44 ET | 934 | 24 |
11:45 ET | 1664 | 23.99 |
11:47 ET | 1178 | 23.97 |
11:49 ET | 6257 | 24.06 |
11:51 ET | 3979 | 24.07 |
11:54 ET | 2250 | 24.09 |
11:56 ET | 2419 | 24.08 |
11:58 ET | 4957 | 24.1 |
12:00 ET | 2976 | 24.12 |
12:02 ET | 900 | 24.119 |
12:03 ET | 800 | 24.1 |
12:05 ET | 1806 | 24.07 |
12:07 ET | 1977 | 24.0925 |
12:09 ET | 4357 | 24.13 |
12:12 ET | 2163 | 24.16 |
12:14 ET | 2234 | 24.16 |
12:16 ET | 4962 | 24.17 |
12:18 ET | 4615 | 24.21 |
12:20 ET | 1677 | 24.24 |
12:21 ET | 5383 | 24.25 |
12:23 ET | 3235 | 24.26 |
12:25 ET | 425 | 24.26 |
12:27 ET | 1310 | 24.265 |
12:30 ET | 1167 | 24.27 |
12:32 ET | 6765 | 24.23 |
12:34 ET | 3690 | 24.2 |
12:36 ET | 469 | 24.2 |
12:38 ET | 512 | 24.22 |
12:39 ET | 3008 | 24.23 |
12:41 ET | 3530 | 24.1898 |
12:43 ET | 700 | 24.175 |
12:45 ET | 1342 | 24.17 |
12:48 ET | 5260 | 24.18 |
12:50 ET | 300 | 24.17 |
12:52 ET | 2453 | 24.19 |
12:54 ET | 1567 | 24.21 |
12:56 ET | 3331 | 24.16 |
12:57 ET | 1300 | 24.16 |
01:01 ET | 9192 | 24.18 |
01:03 ET | 300 | 24.18 |
01:06 ET | 2868 | 24.205 |
01:08 ET | 600 | 24.205 |
01:10 ET | 2667 | 24.185 |
01:12 ET | 1587 | 24.185 |
01:14 ET | 2203 | 24.2 |
01:15 ET | 1477 | 24.2152 |
01:17 ET | 1100 | 24.2 |
01:19 ET | 700 | 24.195 |
01:21 ET | 1039 | 24.19 |
01:24 ET | 1200 | 24.155 |
01:26 ET | 3869 | 24.165 |
01:28 ET | 2004 | 24.15 |
01:30 ET | 1554 | 24.165 |
01:32 ET | 8032 | 24.14 |
01:33 ET | 2531 | 24.135 |
01:35 ET | 3340 | 24.1436 |
01:37 ET | 10766 | 24.15 |
01:39 ET | 300 | 24.15 |
01:42 ET | 3107 | 24.13 |
01:44 ET | 6991 | 24.145 |
01:46 ET | 4367 | 24.135 |
01:48 ET | 3035 | 24.14 |
01:50 ET | 5639 | 24.07 |
01:51 ET | 4345 | 24.03 |
01:53 ET | 900 | 24.025 |
01:55 ET | 1754 | 24.025 |
01:57 ET | 2308 | 24.025 |
02:00 ET | 2909 | 24.035 |
02:02 ET | 751 | 24.035 |
02:04 ET | 2951 | 24.02 |
02:06 ET | 4092 | 23.995 |
02:08 ET | 3153 | 23.975 |
02:09 ET | 1923 | 23.98 |
02:11 ET | 4839 | 24 |
02:13 ET | 1868 | 23.985 |
02:15 ET | 1237 | 23.965 |
02:18 ET | 3385 | 24.01 |
02:20 ET | 2587 | 23.995 |
02:22 ET | 1748 | 23.99 |
02:24 ET | 500 | 23.98 |
02:26 ET | 2404 | 23.97 |
02:27 ET | 2582 | 23.975 |
02:29 ET | 2102 | 23.965 |
02:31 ET | 3649 | 24.025 |
02:33 ET | 2912 | 24 |
02:36 ET | 519 | 24 |
02:38 ET | 15076 | 24.01 |
02:40 ET | 1100 | 24 |
02:42 ET | 3915 | 23.97 |
02:44 ET | 430 | 23.97 |
02:45 ET | 6693 | 23.98 |
02:47 ET | 7526 | 23.925 |
02:49 ET | 1337 | 23.92 |
02:51 ET | 450 | 23.93 |
02:54 ET | 8370 | 24.01 |
02:56 ET | 5515 | 24.005 |
02:58 ET | 2077 | 24.02 |
03:00 ET | 10236 | 24.08 |
03:02 ET | 1743 | 24.06 |
03:03 ET | 11689 | 24.06 |
03:05 ET | 5823 | 24 |
03:07 ET | 1614 | 24.02 |
03:09 ET | 7341 | 24.06 |
03:12 ET | 1300 | 24.05 |
03:14 ET | 4239 | 24.0601 |
03:16 ET | 804 | 24.06 |
03:18 ET | 1952 | 24.055 |
03:20 ET | 1200 | 24.06 |
03:21 ET | 800 | 24.055 |
03:23 ET | 3829 | 24.055 |
03:25 ET | 3551 | 24.06 |
03:27 ET | 800 | 24.06 |
03:30 ET | 1856 | 24.06 |
03:32 ET | 5027 | 24.055 |
03:34 ET | 10847 | 24.07 |
03:36 ET | 4536 | 24.11 |
03:38 ET | 5090 | 24.085 |
03:39 ET | 1900 | 24.06 |
03:41 ET | 3573 | 24.06 |
03:43 ET | 2798 | 24.0575 |
03:45 ET | 1849 | 24.055 |
03:48 ET | 20614 | 24.06 |
03:50 ET | 7267 | 24.055 |
03:52 ET | 18167 | 24.1 |
03:54 ET | 19270 | 24.09 |
03:56 ET | 27421 | 24.05 |
03:57 ET | 19049 | 24.09 |
03:59 ET | 40130 | 24.05 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Alkermes Plc | 4.1B | 6.9x | --- |
Exelixis Inc | 6.4B | 33.9x | -21.77% |
Sinovac Biotech Ltd | 639.9M | -1.8x | +15.89% |
PTC Therapeutics Inc | 2.5B | -4.3x | --- |
Halozyme Therapeutics Inc | 5.1B | 18.9x | --- |
P3 Health Partners Inc | 202.1M | -1.0x | --- |
Alkermes plc is a global biopharmaceutical company that seeks to develop medicines in the field of neuroscience. The Company has a portfolio of commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical candidates in development for neurological disorders. It focuses on commercial products, such as LYBALVI, ARISTADA/ARISTADA INITIO and VIVITROL, and advancing the development of pipeline programs focused on neurological disorders. LYBALVI is a once-daily, oral atypical antipsychotic drug for the treatment of adults with schizophrenia and for the treatment of adults with bipolar I disorder, as a maintenance monotherapy or for the acute treatment of manic or mixed episodes, as monotherapy or an adjunct to lithium or valproate. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia. It has a manufacturing facility in Wilmington, Ohio.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.1B |
---|---|
Revenue (TTM) | $1.7B |
Shares Outstanding | 169.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.46 |
EPS | $3.50 |
Book Value | $7.20 |
P/E Ratio | 6.9x |
Price/Sales (TTM) | 2.4 |
Price/Cash Flow (TTM) | 6.1x |
Operating Margin | 29.25% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.